GOGO

SEC source: 0001209191-20-036904 · doc4.xml · derivative · entry 1

Elias Marguerite M · CIK 0001297509 · EVP, Gen Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 51,500 shares

Expires 2021-12-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 61,800 shares granted on 6/5/13, (iii) options to purchase 80,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (vii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (viii) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 204,045 shares of common stock, having an exercise price of $2.61 per share.

F1 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of December 14, 2011, subject to continued employment with the Company.

SEC source: 0001209191-20-036906 · doc4.xml · derivative · entry 6

ROWAN BARRY L · CIK 0001253821 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,414

Underlying: Common Stock · 249,414 shares

Expires 2030-06-12

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase (A) 200,000 shares and (B) 100,000 shares granted on 4/24/17, (ii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18 and (iii) 50,000 shares granted on 4/30/19. In exchange, the reporting person received replacement options to purchase 249,414 shares of common stock, having an exercise price of $2.61 per share.

F7 · derivative.exercise_date: These options vest on December 31, 2022, subject to continued employment with the Company.

SEC source: 0001209191-20-036906 · doc4.xml · derivative · entry 5

ROWAN BARRY L · CIK 0001253821 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2029-04-30

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase (A) 200,000 shares and (B) 100,000 shares granted on 4/24/17, (ii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18 and (iii) 50,000 shares granted on 4/30/19. In exchange, the reporting person received replacement options to purchase 249,414 shares of common stock, having an exercise price of $2.61 per share.

F6 · derivative.exercise_date: These options provided for vesting as follows: (i) 50% of the options vest on December 31, 2020 and (ii) the remaining 50% vest on December 31, 2021, subject to continued employment with the Company.

SEC source: 0001209191-20-036906 · doc4.xml · derivative · entry 4

ROWAN BARRY L · CIK 0001253821 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,000 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase (A) 200,000 shares and (B) 100,000 shares granted on 4/24/17, (ii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18 and (iii) 50,000 shares granted on 4/30/19. In exchange, the reporting person received replacement options to purchase 249,414 shares of common stock, having an exercise price of $2.61 per share.

F5 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036906 · doc4.xml · derivative · entry 3

ROWAN BARRY L · CIK 0001253821 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,000 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase (A) 200,000 shares and (B) 100,000 shares granted on 4/24/17, (ii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18 and (iii) 50,000 shares granted on 4/30/19. In exchange, the reporting person received replacement options to purchase 249,414 shares of common stock, having an exercise price of $2.61 per share.

F4 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036906 · doc4.xml · derivative · entry 2

ROWAN BARRY L · CIK 0001253821 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2027-04-24

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase (A) 200,000 shares and (B) 100,000 shares granted on 4/24/17, (ii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18 and (iii) 50,000 shares granted on 4/30/19. In exchange, the reporting person received replacement options to purchase 249,414 shares of common stock, having an exercise price of $2.61 per share.

F3 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of April 24, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036906 · doc4.xml · derivative · entry 1

ROWAN BARRY L · CIK 0001253821 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200,000 shares

Expires 2027-04-24

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase (A) 200,000 shares and (B) 100,000 shares granted on 4/24/17, (ii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18 and (iii) 50,000 shares granted on 4/30/19. In exchange, the reporting person received replacement options to purchase 249,414 shares of common stock, having an exercise price of $2.61 per share.

F1 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of April 24, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 13

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,171

Underlying: Common Stock · 219,171 shares

Expires 2030-06-12

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F14 · derivative.exercise_date: These options vest on December 31, 2022, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 12

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,200 shares

Expires 2029-03-10

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F13 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of March 10, 2019, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 11

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,550 shares

Expires 2029-03-10

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F12 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of March 10, 2019, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 10

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,000 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F11 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 9

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,000 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F10 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 8

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,840 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F9 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 7

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 58,340 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F8 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 6

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,400 shares

Expires 2026-08-31

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F7 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2016, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 5

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64,600 shares

Expires 2026-06-24

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F6 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2016, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 4

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64,600 shares

Expires 2025-05-26

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F5 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2015, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 3

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2024-05-28

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F4 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 28, 2014, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 2

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 82,400 shares

Expires 2023-06-05

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F3 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of June 5, 2013, subject to continued employment with the Company.

SEC source: 0001209191-20-036908 · doc4.xml · derivative · entry 1

WADE JOHN · CIK 0001579578 · President, CA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 82,400 shares

Expires 2021-12-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 82,400 shares granted on 12/14/11, (ii) options to purchase 82,400 shares granted on 6/5/13, (iii) options to purchase 100,000 shares granted on 5/28/14, (iv) options to purchase 64,600 shares granted on 5/26/15, (v) options to purchase 64,600 shares granted on 6/24/16, (vi) options to purchase 19,400 shares granted on 8/31/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 219,171 shares of common stock, having an exercise price of $2.61 per share.

F1 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of December 14, 2011, subject to continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 8

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,951

Underlying: Common Stock · 56,951 shares

Expires 2030-06-12

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F9 · derivative.exercise_date: These options vest on December 31, 2022, subject to continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 7

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,525 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F8 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 6

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,575 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F7 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 5

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,710 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F6 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 4

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,000 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F5 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 3

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,600 shares

Expires 2026-06-24

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F4 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2016, subject to the continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 2

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,900 shares

Expires 2025-05-26

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F3 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2015, subject to continued employment with the Company.

SEC source: 0001209191-20-036905 · doc4.xml · derivative · entry 1

Jackson Karen · CIK 0001634791 · EVP, Chief People Exp. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,810 shares

Expires 2025-02-27

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 31,810 shares granted on 2/27/15, (ii) options to purchase 6,900 shares granted on 5/26/15, (iii) options to purchase 30,600 shares granted on 6/24/16, (iv) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (v) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 56,951 shares of common stock, having an exercise price of $2.61 per share.

F1 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of February 27, 2015, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 13

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,598

Underlying: Common Stock · 203,598 shares

Expires 2030-06-12

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F14 · derivative.exercise_date: These options vest on December 31, 2022, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 12

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,200 shares

Expires 2029-03-10

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F13 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of March 10, 2019, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 11

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,550 shares

Expires 2029-03-10

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F12 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of March 10, 2019, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 10

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,000 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F11 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 9

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,000 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F10 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 8

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,840 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F9 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 7

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 58,340 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F8 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 6

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64,600 shares

Expires 2026-06-24

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F7 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2016, subject to the continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 5

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64,600 shares

Expires 2025-05-26

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F6 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2015, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 4

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,414 shares

Expires 2024-09-22

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F5 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of September 22, 2014, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 3

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2024-05-28

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F4 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 28, 2014, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 2

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,200 shares

Expires 2023-06-05

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F3 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of June 5, 2013, subject to continued employment with the Company.

SEC source: 0001209191-20-036903 · doc4.xml · derivative · entry 1

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 51,500 shares

Expires 2021-12-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 51,500 shares granted on 12/14/11, (ii) options to purchase 41,200 shares granted on 6/5/13, (iii) options to purchase 50,000 shares granted on 5/28/14, (iv) options to purchase 32,414 shares granted on 9/22/14, (v) options to purchase 64,600 shares granted on 5/26/15, (vi) options to purchase 64,600 shares granted on 6/24/16, (vii) options to purchase (A) 58,340 shares and (B) 29,840 shares granted on 3/14/17, (viii) options to purchase (A) 37,000 shares and (B) 37,000 shares granted on 2/17/18, and (ix) options to purchase (A) 60,550 shares and (B) 20,200 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 203,598 shares of common stock, having an exercise price of $2.61 per share.

F1 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of December 14, 2011, subject to continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 8

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,516

Underlying: Common Stock · 65,516 shares

Expires 2030-06-12

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F9 · derivative.exercise_date: These options vest on December 31, 2022, subject to continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 7

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires 2029-03-10

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F8 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of March 10, 2019, subject to continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 6

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,525 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F7 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 5

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,575 shares

Expires 2028-02-17

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F6 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of February 17, 2018, subject to continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 4

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,710 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F5 · derivative.exercise_date: Following the elimination of the performance conditions for these options by the Compensation Committee of the Company, these options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 3

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,000 shares

Expires 2027-03-14

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F4 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of March 14, 2017, subject to continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 2

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,500 shares

Expires 2026-06-24

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F3 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of May 26, 2016, subject to the continued employment with the Company.

SEC source: 0001209191-20-036902 · doc4.xml · derivative · entry 1

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,429 shares

Expires 2025-08-31

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 41,429 shares granted on 8/31/15, (ii) options to purchase 25,500 shares granted on 6/24/16, (iii) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17, (iv) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18, and (v) options to purchase 19,000 shares granted on 3/10/19. In exchange, the reporting person received replacement options to purchase 65,516 shares of common stock, having an exercise price of $2.61 per share.

F1 · derivative.exercise_date: These options provided for vesting in four annual installments beginning on the first anniversary of August 31, 2015, subject to continued employment with the Company.

SEC source: 0001209191-20-036901 · doc4.xml · derivative · entry 10

Aguirre Sergio A. · CIK 0001738955 · President, BA division

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,946

Underlying: Common Stock · 52,946 shares

Expires 2030-06-12

F2 · price: On 6/12/20, pursuant to its option exchange program, the issuer cancelled the following options to purchase shares of common stock held by the reporting person: (i) options to purchase 5,150 shares granted on 12/14/11, (ii) options to purchase 2,575 shares granted on 6/10/13, (iii) options to purchase 11,426 shares granted on 5/30/14, (iv) options to purchase 10,000 shares granted on 5/26/15, (v) options to purchase 27,800 shares granted on 6/24/16, (vi) options to purchase (A) 23,000 shares and (B) 7,710 shares granted on 3/14/17 and (vii) options to purchase (A) 19,575 shares and (B) 6,525 shares granted on 2/17/18. In exchange, the reporting person received replacement options to purchase 52,946 shares of common stock, having an exercise price of $2.61 per share.

F11 · derivative.exercise_date: These options vest on December 31, 2022, subject to continued employment with the Company.